Immunomodulating activity of analogs of noninflammatory fragment 163-171 of human interleukin-1β

Immunopharmacology

Volumn 38, Issue 3, 1998, Pages 237-245

  Bajpai, K ^a   Singh, V K ^a   Sharan, R ^b   Yadav, V S ^a   Haq, W ^b   Mathur, K B ^b   Agarwal, S S ^a  

^a Dept Immunol Sanjay Gandhi P   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Interleukin 1 nonapeptide; Mouse thymocytes; Synthetic analogs

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN DERIVATIVE; NONAPEPTIDE; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE;

ACUTE-PHASE PROTEINS; ADJUVANTS, IMMUNOLOGIC; ANIMALS; BLOOD GLUCOSE; BODY TEMPERATURE; CARRIER PROTEINS; CELL DIVISION; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1BETA; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; RADIATION-PROTECTIVE AGENTS; STRUCTURE-ACTIVITY RELATIONSHIP; THYMUS GLAND; TUMOR CELLS, CULTURED;

EID: 0031909389     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00070-2     Document Type: Article

References (45)

1. Antoni G., Presentini R., Perin F., Tagliabue A., Ghiara P., Censini S., Volpini G., Villa L., Boraschi D. A short synthetic fragment of human interleukin-1 with immunostimulatory but not inflammatory activity. J. Immunol. 137:1986;3201-3204.
2. Bajpai K., Singh V.K., Agarwal S.S., Dhawan V.C., Haq W., Mathur K.B. Immunomodulatory activity of met-enkephalin and its two potent analogs. Int. J. Immunopharmacol. 17:1995;207-212.
3. Bajpai K., Singh V.K., Dhawan V.C., Haq W., Mathur K.B., Agarwal S.S. Immunomodulation by two potent analogs of met-enkephalin. Immunopharmacology. 35:1997;213-220.
4. Booth R.J., Prestidge R.L., Watson J.D. Interleukin-1 and B-cell responsiveness. Lymphokines. 12:1985;75-85.
5. Boraschi D., Nencioni L., Villa L., Cesini S., Bossu P., Ghiara P., Presentini R., Perin F., Frasca D., Doria G., Forni G., Musso T., Giovarelli M., Ghezzi P., Bertini R., Besedovsky H.O., Rey A.D., Sipe J.D., Antoni G., Silvestrin S., Tagliabue A. In vivo stimulation and restoration of the immune response by the non-inflammatory fragment 163-171 of human interleukin-1β J. Exp. Med. 168:1988;675-686.
6. Boraschi D., Volpini G., Villa L., Nencioni L., Scapigliati G., Nucci D., Antoni G., Matteucci G., Cioli F., Tagliabue A. A monoclonal antibody to the IL-1β peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1β in vivo. J. Immunol. 143:1989;131-134.
7. Boraschi D., Antoni G., Perin F., Villa L., Nencioni L., Ghiara P., Presentini R., Tagliabue A. Defining the structural requirements of a biologically active domain of human IL-1R beta. Eur. Cytokine Netw. 1:1990;21-26.
8. Boraschi D., Ghiara P., Scapigliati G., Villa L., Sette A., Tagliabue A. Binding and internalization of the 163-171 fragment of human IL-1β Cytokine. 4:1992;201-204.
9. Chatterjee-Kishore M., Agrawal S., Singh V.K., Mathur K.B., Agarwal S.S., Upregulation of H.L. A class-I gene transcription in K562 cells by analogs of splenopentin (S.P.-5). Biochem. Mol. Biol. Int. 41:1997;521-528.
10. DeChiara T.M., Young D., Semionow R., Stern A.S., Batula-Bernardo C., Fiedler-Nagy C., Kaffka K.L., Kilian P.L., Yamazaki S., Mizel S.B., Lomedico P.T. Structure-function analysis of murine interleukin-1: Biologically active polypeptides are at least 127 amino acid long and are derived from the carboxy terminus of a 270 amino acid precursors. Proc. Natl. Acad. Sci. USA. 83:1986;8303-8307.
11. Dinarello C.A. Interleukin-1 and its biologically related cytokines. Adv. Immunol. 44:1989;153-205.
12. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood. 77:1991;1627-1652.
13. Dinarello C.A. The biological properties of interleukin-1. Eur. Cytokine Netw. 5:1994;517-531.
14. Dinarello C.A. Biological basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
15. Epstein F.H. Interleukin-1 and the pathogens of the acute phase response. New Engl. J. Med. 311:1984;1413-1418.
16. Forni G., Musso T., Jemma C., Boraschi D., Tagliabue A., Giovarelli M. Lymphokine-activated tumor inhibition in mice. Ability of a nonapeptide of the human IL-1β to recruit anti-tumor reactivity in recipient mice. J. Immunol. 142:1989;712-718.
17. Frasca D., Boraschi D., Baschieri S., Bossu P., Tagliabue A., Adorini L., Doria G. In vivo restoration of T-cell functions by human IL-1β or its 163-171 nonapeptide in immunodepressed mice. J. Immunol. 141:1988;2651-2655.
18. Frasca D., Baschieri S., Boraschi D., Tagliabue A., Doria G. Radiation protection and restoration by the synthetic 163-171 nonapeptide of human interleukin 1β Radiat. Res. 128:1991;43-47.
19. Ho S.N., Abraham R.T., Nilson A., Handwerger B.S., McKeen D.J. Interleukin-1 mediated activation of interleukin-4 producing T lymphocytes. Proliferation by IL-4-dependent and IL-4-independent mechanisms. J. Immunol. 139:1987;1532-1540.
20. Lerner U.H., Ljunggren O., Dewhirst F.E., Boraschi D. Comparison of human interleukin-1β and its 163-171 peptide in bone resorption and the immune response. Cytokine. 3:1991;141-148.
21. Lipsky P.E. Role of interleukin-1 in human B-cell activation. Contemp. Top. Mol. Immunobiol. 10:1985;195-217.
22. Lowenthal J.W., Cerottini J.C., MacDonald H.R. Interleukin-1 dependent induction of both interleukin-2 secretion and interleukin-2 receptor expression by thymoma cells. J. Immunol. 137:1986;1226-1231.
23. McCune C.S., Marquis D.M. Interleukin-1 as an adjuvant for active specific immunotherapy in a murine tumor model. Cancer Res. 50:1990;1212-1215.
24. Moore M.A.S., Warren D.J. Synergy of interleukin-1 and granulocyte colony stimulating factor: In vivo stimulation of stem cells recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc. Natl. Acad. Sci. USA. 84:1987;7134-7138.
25. 1 arrest of a human melanoma cell line by IL-1. Biochem. Biophys. Res. Commun. 173:1990;186-192.
26. Mosley B., Dower S.K., Gillis S., Cosman D. Determination of minimum polypeptide lengths of the functionally active sites of human interleukin-1α and 1β Proc. Natl. Acad. Sci. USA. 84:1987;4572-4576.
27. Nencioni L., Villa L., Tagliabue A., Antoni G., Presentini R., Perin F., Silvestrin S., Boraschi D. In vivo immunostimulating activity of the 163-171 peptide of human IL-1β J. Immunol. 139:1987;800-804.
28. Neta R., Douches S., Oppenheim J.J. Interleukin-1 is a radioprotector. J. Immunol. 136:1986;2483-2485.
29. Pessina G.P., Bocci V., Nicoletti C., Becherucci C., Presentini R., Parente L., Villa L., Tagliabue A., Boraschi D. Metabolic behaviour and distribution of the synthetic nonapeptide fragment 163-171 of human IL-1β Lymphokine Res. 9:1990;371-379.
30. Pike B.L., Nossal G.J. Interleukin-1 can act as a B-cell growth and differentiation factor. Proc. Natl. Acad. Sci. USA. 82:1985;8153-8157.
31. Pujol J.P., Loyau G. Interleukin-1 and osteoarthritis. Life Sci. 41:1987;1187-1198.
32. Puri A., Rizvi S.Y., Haq W., Kundu B., Saxena R.P., Shukla R., Mathur K.B., Saxena K.C. Immunostimulant activity of novel lipopeptide and its protective action against L. donovani infection. Immunopharmacol. Immunotoxicol. 15:1993;539-556.
33. Rao K.V.S., Nayak A.R. Enhanced immunogenicity of a sequence derived from hepatitis B virus surface antigen in a composite peptide that includes the immunostimulatory region from human interleukin-1. Proc. Natl. Acad. Sci. USA. 87:1990;5519-5522.
34. Rastogi A., Singh V.K., Biswas S., Haq W., Mathur K.B., Agarwal S.S. Augmentation of human natural killer cells by splenopentin analogs. FEBS Lett. 317:1993;93-95.
35. Sahai R., Puri A., Saxena R.P., Sharan R., Haq W., Kundu B., Mathur K.B. Synthesis and immunostimulant activity of novel analogs of human casein fragment (54-59). Immunopharmacol. Immunotoxicol. 18:1996;511-525.
36. Siddiqui Z., Sharma A.K., Kumar S., Kumar A., Bhatt P.N. Conformation of a T-cell stimulating peptide of interleukin-1β protein: Circular dichroism studies. Int. J. Biol. Macromol. 16:1994;259-263.
37. Sharma, P., Anuradha, Sharan, R., Haq, W., Kundu, K.B., Katiyar, J.C., Mathur, B., 1996. Stimulation of non-specific resistance by human casein fragment (54-59) and its synthetic analogues against Leismania donovani infection. Protein Pep. Lett. 3, 329-334.
38. Singh P.P., Dhawan V.C., Haq W., Mathur K.B., Dutta G.P., Srimal R.C., Dhawan B.N. Enkephalin modulation of Plasmodium cynomolgi antigen-induced colony stimulating factors elaboration by macrophages. J. Biol. Regul. Homeostatic Agents. 5:1991;142-146.
39. Singh P.P., Dhawan V.C., Haq W., Mathur K.B., Dutta G.P., Srimal R.C., Dhawan B.N. Lymphokines production by concanavalin-A stimulated mouse splenocytes: Modulation by met-enkephalin and related peptide. Immunopharmacology. 27:1994;245-251.
40. Singh V.K., Anand R., Sharma K., Agarwal S.S. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant E. coli expressing retinal S-antigen. Cell Immunol. 172:1996;158-162.
41. Smith K.A., Lachman L.B., Oppenheim J.J., Favata M.F. The functional relationship of interleukins. J. Exp. Med. 151:1980;1551-1556.
42. Tagliabue A., Boraschi D. Cytokines as vaccine adjuvants: Interleukin-1 and its synthetic peptide 163-171. Vaccine. 11:1993;594-595.
43. Tagliabue A., Antoni G., Boraschi D. Defining agonist peptides of human interleukin-1β Lymphokine Res. 8:1989;311-315.
44. Yoshiaki K., Kaoru I., Shizno N., Kouki K., Tadashi A., Hideki M. A deblocking method using thioester sulphonic acid system application to the synthesis of met-enkephalin. Chem. Pharm. Bull. 2:1979;A72.
45. Zar, Z.H., 1984. Biostatistical Analysis. New Jersey, Prentice-Hall International.